ABI-LAB News

News | ABI-LAB

New Advisory Program with Alira Health

Natick, MASSACHUSETTS – July 16, 2019 – ABI-LAB, a biotech incubator facility firm, announced the launch of an acceleration office hours program with Alira Health to benefit current residents. ABI-LAB is an accelerator and bio-incubator established to support startups, including life science, biotech, medical technology, and medical data companies.
Read more

Karyopharm Therapeutics granted FDA approval

Please join me in congratulating Karyopharm Therapeutics. Karyopharm Therapeutics, on July 3rd, 2019 was granted FDA approval for its Multiple Myeloma Drug, Xpovio. Dr. Raphael Nir helped foster and conduct early research stages through SBH Sciences drug optimization services.
Read more

Framingham Hosts Life Sciences Executives from All Over the World

Bus Tour for BIO Conference Participants Highlight the Benefits of Locating in Metrowest On Friday, June 8th, 50 executives from Life Sciences companies boarded a bus in Boston and took the 30-minute ride to Framingham and Natick.  The executives, who had attended the international BIO Conference that took place at the Boston Convention and Exhibition […]
Read more

ABI-LAB Celebrates its Grand Opening in Natick Massachusetts

Natick, MA – Wednesday, September 28, 2016 – CEO of Karyopharm Therapeutics Inc., Dr. Michael Kauffman, joined by State Senator Karen Spilka, State Senator Richard Ross, State Representative David Linsky, Paul Joseph, President & CEO of the Metrowest Chamber of Commerce, and Angus McQuilken, Vice President for Communications & Marketing for the Massachusetts Life Science […]
Read more

Natick company aims to help start-up biotech firms

NATICK – When people receive medication at the hospital, from a pharmacy or over the counter, they are likely benefiting from what was once just a concept. “Every one of these started with some scientist with an idea,” said Dr. Michael Kauffman, CEO of Karyopharm Therapeutics, a Newton-based pharmaceutical company that develops drugs for the […]
Read more